http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d2a80a60a2247386fc0e611c8114bf84
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Howell |
| name | Anthony Howell |
| given-name | Anthony |
| organization-name | University Hospital of South Manchester, Manchester, UK; University of Manchester, Manchester, UK 9Christie Hospital, Withington, Manchester, United Kingdom; Division of Cancer Sciences, University of Manchester, Manchester, UK Nightingale and Prevent Breast Cancer Research Unit, Manchester University NHS Foundation Trust, Manchester, UK 1Medical Oncology and Departments of Manchester Breast Centre & Breakthrough Breast Cancer Research Unit; Paterson Institute for Cancer Research; School of Cancer, Enabling Sciences and Technology; Manchester Academic Health Science Centre; University of Manchester; Manchester, UK Breakthrough Breast Cancer Research Unit and the Manchester Breast Centre; Institute of Cancer Sciences; University of Manchester; Manchester, UK. Division of Cancer Sciences, University of Manchester , Manchester, UK Nightingale/Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester University NHS Foundation Trust Manchester UK; Manchester Breast Centre, Manchester Cancer Research Centre The Christie Hospital Manchester UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester Manchester Academic Health Science Centre Manchester UK Manchester Breast Center and Breakthrough Breast Cancer Research Unit, Manchester Academic Health Science Centre, University of Manchester, Manchester M20 4BX, United Kingdom Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Wythenshawe, Manchester, UK; From the Royal Marsden Hospital; Wolfson Institute for Preventive Medicine, Queen Mary University of London; University College London, London; Royal Infirmary Glasgow; Christie Hospital, Manchester, United Kingdom; Newcastle Mater Hospital, Newcastle, New South Wales, Australia; The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Genomic Health, Redwood City, CA. From Cancer Research UK; Queen Mary University of London, London; Royal Marsden Hospital; Christie Hospital National Health Service Trust; Cancer Research UK, Manchester, United Kingdom; Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Dresden, Germany; and University of Newcastle, Newcastle, Australia. Prevent Breast Cancer Research Unit Manchester University Hospital NHS Foundation Trust Manchester UK From the Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom. 1Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom.; 3Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Christie Hospital, Withington, Manchester, United Kingdom. From the Academic Unit of Bone Metabolism, University of Sheffield; Cancer Research Centre, Weston Park Hospital, Sheffield; Department of Diagnostic Radiology, University of Manchester; Christie Hospital National Health Service Trust, Manchester; Wolfson Institute of Preventive Medicine, London; AstraZeneca, Cheshire, United Kingdom; Cross Cancer Institute, Edmonton, Alberta, Canada; Universität Erlangen-Nurnberg, Erlangen, Germany Cancer Research Campaign Psychosocial Oncology Group, University of Sussex; Imperial Cancer Research Fund, Lincoln’s Inn Fields, London; Royal Marsden National Health Services Trust, London; and Christie Hospital NHS Trust, Manchester, United Kingdom. 4Christie Hospital, Manchester Breast Centre and Breakthrough Breast Cancer Research Unit, Manchester, United Kingdom. Jack Cuzick, Adam R. Brentnall, Caroline Reuter, and Ivana Sestak, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Corrinne Segal, The Institute of Cancer Research; Corrinne Segal, Simone Detre, Elena Lopez-Knowles, and Mitchell Dowsett, Royal Marsden Hospital; Trevor J. Powles, Cancer Centre London, London; Helen Byers and William G. Newman, University of Manchester and Central Manchester Foundation Trust; and Anthony Howell, The Christie NHS... 1Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom. Nightingale and Prevent Breast Cancer Ctr., Univ. Hospital of South Manchester (United Kingdom) 42Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom. University of Manchester Division of Cancer Sciences, The University of Manchester, Manchester, UK. CRC Department Medical Oncology, University of Manchester Christie Hospital and Holt Radium Inst., Manchester, UK. Prevention Breast Cancer Centre and Nightingale Breast Screening Centre University Hospital of South Manchester Manchester United Kingdom; The Christie NHS Foundation Trust Manchester United Kingdom; Manchester Breast Centre, Manchester Cancer Research Centre University of Manchester Manchester United Kingdom The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, The University of Manchester and Manchester University NHS foundation trust; The Christie NHS Foundation Trust, Manchester, UK Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK. From the Cancer Research UK Psychosocial Oncology Group, Brighton & Sussex Medical School, University of Sussex, Brighton; Cancer Research UK, Wolfson Institute of Preventive Medicine, London; AstraZeneca, Cheshire; Cancer Research UK, Department of Medical Oncology, Christie Hospital, University of Manchester, Manchester, United Kingdom; and Center on Outcomes Research and Education (CORE), and Kellogg Cancer Care Center, Evanston Northwestern Healthcare and Northwestern University, Evanston, IL Authors' Affiliations: 1Genesis Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester; 2Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, and Central Manchester Foundation Trust; Schools of 3Cancer and Enabling Sciences and 4Community Based Medicine, University of Manchester; 5The Christie NHS Foundation Trust, Withington, Manchester; 6Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; and 7Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, United Kingdom; Authors' Affiliations: 1Genesis Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester; 2Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, and Central Manchester Foundation Trust; Schools of 3Cancer and Enabling Sciences and 4Community Based Medicine, University of Manchester; 5The Christie NHS Foundation Trust, Withington, Manchester; 6Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; and 7Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, United Kingdom; Authors' Affiliations: 1Genesis Prevention Centre and Nightingale Breast Screening Centre, University Hospital of South Manchester; 2Genetic Medicine, Manchester Academic Health Sciences Centre, University of Manchester, and Central Manchester Foundation Trust; Schools of 3Cancer and Enabling Sciences and 4Community Based Medicine, University of Manchester; 5The Christie NHS Foundation Trust, Withington, Manchester; 6Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; and 7Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge, United Kingdom Authors' Affiliations: 1Department of Genetic Medicine, The University of Manchester, Manchester Academic Health Science Centre, St. Mary's Hospital; 2Genesis Prevention Centre, University Hospital of South Manchester Southmoor Road; 3Centre for Health Informatics, Institute of Population Health, The University of Manchester, Manchester; and 4Centre for Rare Diseases and Personalised Medicine, School of Clinical and Experimental Medicine, University of Birmingham College of Medical and Dental Sciences, and West Midlands Regional Genetics Service, Birmingham, United Kingdom CRUK Department of Medical Oncology, Christie Hospital NHS Trust, Wilmslow Road, Withington, Manchester, M20 4BX, UK, Tel.: +44 161 446 8037; Fax: +44 161 446 8000; Division of Cancer Sciences University of Manchester Manchester UK University of Manchester and University Hospital of South Manchester, Manchester, United Kingdom (A.H.) From the Medical Research Council Clinical Trials Unit; Department of Oncology, University College London; Cancer Research UK (CRUK), Department of Molecular Oncology, Nottingham; CRUK, Department of Oncology, Manchester, United Kingdom; Department of Oncology, Western General Hospital and University of Edinburgh, Edinburgh, Scotland Division of Cancer Sciences, Faculty of Biology, Medicine and Health; Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester; Prevent Breast Cancer Research Unit, The Nightingale Centre, Wythenshawe Hospital; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester From the CRC Department of Medical Oncology and Paterson Institute for Cancer Research, Christie Hospital, Manchester; ICRF Clinical Oncology Unit, Guy’s Hospital, London; CRC Institute of Cancer Studies, Birmingham; Department of Medical Statistics, Christie Hospital, Manchester; and British Biotech plc, Oxford, UK. The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University of Manchester, UK; The Breakthrough Breast Cancer Research Unit, Institute of Cancer Sciences, University of Manchester, UK Authors' Affiliations: 1Breast Biology Group and 2Medical Oncology, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom; 3Cancer and Infection Research Area, AstraZeneca, Macclesfield, Cheshire, United Kingdom; and 4Breakthrough Research Unit, Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom Prevention Breast Cancer Centre and Nightingale Breast Screening Centre, Manchester University Hospital Foundation Trust, Manchester, England; Manchester Breast Centre, Manchester Cancer Research Centre, University of Manchester, Manchester, England; The Christie NHS Foundation Trust, Manchester, United Kingdom Genesis Breast Cancer Prevention Centre, Manchester, UK. 1Medical Genetics Research Group and Regional Genetic Service, The University of Manchester, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, St. Mary's Hospital; 2Department of Psycho-Oncology and 3Cancer Research UK Medical Oncology, The Christie NHS Trust; 4Genesis Prevention Center and Departments of 5Surgery and 6Plastic Surgery, University Hospital of South Manchester NHS Trust, Manchester, United Kingdom; 1Medical Genetics Research Group and Regional Genetic Service, The University of Manchester, Manchester Academic Health Science Centre, Central Manchester Foundation Trust, St. Mary's Hospital; 2Department of Psycho-Oncology and 3Cancer Research UK Medical Oncology, The Christie NHS Trust; 4Genesis Prevention Center and Departments of 5Surgery and 6Plastic Surgery, University Hospital of South Manchester NHS Trust, Manchester, United Kingdom Genesis Prevention Centre, University Hospital of South Manchester, Manchester, UK. anthony.howell@christie.nhs.uk Manchester Breast Centre & Breakthrough Breast Cancer Research Unit, Paterson Institute for Cancer Research; School of Cancer, Enabling Sciences and Technology, Manchester Academic Health Science Centre, University of Manchester, UK Genesis Prevention Centre, University Hospital of South Manchester, Wythenshawe, Manchester, United Kingdom Samuel George Smith, Leeds Institute of Health Science, University of Leeds, Leeds; Samuel George Smith, Ivana Sestak, and Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; Anthony Howell, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom; and John Forbes, Calvary Mater Newcastle Hospital, Newcastle, Australia. The Breakthrough Breast Cancer Research Unit, Institute of Cancer Sciences, University of Manchester, UK; The Manchester Centre for Cellular Metabolism (MCCM), Institute of Cancer Sciences, University of Manchester, UK 1University Department of Medical Oncology, Christie Hospital, Manchester, United Kingdom; Authors' Affiliations: 1Breast Biology Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester; 2Genesis Breast Cancer Prevention and Nightingale Centres, University Hospital of South Manchester NHS Trust; 3Manchester Centre for Integrative Systems Biology and 4School of Chemistry, The Manchester Interdisciplinary Biocentre, The University of Manchester; 5Breakthrough Breast Cancer Research Unit, Paterson Institute for Cancer Research, Manchester, United Kingdom From the Christie Hospital and Holt Radium Institute, Manchester; City Hospital, Nottingham; Belvoir Park Hospital, Belfast, United Kingdom; Cancer Research Centre of Russian Academy of Medical Sciences, Moscow, Russia; Breast Center at Baylor College of Medicine and the Methodist Hospital, Houston, TX; Istituto Nazionale Tumori, Milan, Italy; National Cancer Center Hospital, Tokyo, Japan; and AstraZeneca, Wilmington, DE From the Department of Gynecology and Obstetrics, Goethe University, Frankfurt am Main; Red Cross Gynecological Hospital; University Groβhadern, Munich; Charité Hospital, Berlin; University of Heidelberg, Heidelberg; General Hospital, Hagen; General Hospital, Bayreuth; University Hospital, Ulm; Germany; National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, PA; The University of Texas M.D. Anderson Cancer Center, Houston, TX; National Cancer Institute, Milan, Italy; Christie Hospital NHS Trust,... The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Breakthrough Breast Cancer Research Unit; Institute of Cancer Sciences; University of Manchester; Manchester, UK CRUK Department of Medical Oncology, Christie Hospital, University of Manchester, UK. Manchester Breast Centre, The Christie NHS Foundation Trust, University of Manchester, Manchester, UK Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, UK Christie Hospital, Manchester, UK Alistair Ring, Brighton and Sussex Medical School, Sussex Cancer Centre, Brighton; Ivana Sestak and Jack Cuzick, Cancer Research UK Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine; Michael Baum, Cancer Research UK/University College London Cancer Trials Centre, University College London; Mitch Dowsett, Royal Marsden Hospital, London; Anthony Howell, The Christie National Health Service Trust, University of Manchester, Manchester, United Kingdom; Aman Buzdar,... Christie Hospital NHS Trust, University of Manchester, CRUK Department of Medical Oncology, UK. maria.parker@christie-tr.nwest.nhs.uk Jack Cuzick, Silvia Pineda, and Christopher Wale, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London; Mitch Dowsett, Janine Salter, Emma Quinn, and Lila Zabaglo, Royal Marsden Hospital, London; Elizabeth Mallon, Western Infirmary, North Glasgow University Hospital, Glasgow; Andrew R. Green and Ian O. Ellis, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals National Health Services Trust, City Hospital,... Francesco Spagnolo, Ivana Sestak, and Jack Cuzick, Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London; Anthony Howell, Genesis Breast Cancer Prevention Centre, University Hospital of South Manchester, Manchester, United Kingdom; and John F. Forbes, Department of Surgical Oncology, University of Newcastle, Newcastle Mater Hospital, New South Wales, Australia Manchester Breast Centre & Breakthrough Breast Cancer Research Unit, Paterson Institute for Cancer Research, University of Manchester, Manchester, United Kingdom.; School of Cancer, Enabling Sciences and Technology, Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom. Christie Hospital National Health Services Trust, Manchester, United Kingdom Andrew G. Renehan, Sacha Howell, and Anthony Howell, University of Manchester; Michelle Harvie and Anthony Howell, University Hospital of South Manchester NHS Foundation Trust, Manchester; Ramsey I. Cutress, University Hospitals Southampton; Ramsey I. Cutress, University of Southampton, Southampton, United Kingdom; Michael Leitzmann, University of Regensburg, Regensburg; and Tobias Pischon, Max Delbrück Center for Molecular Medicine (MDC), Berlin-Buch, Germany 10Christie Hospital, Withington, Manchester, United Kingdom; Manchester Breast Centre & Breakthrough Breast Cancer Research Unit; Paterson Institute for Cancer Research; School of Cancer, Enabling Sciences and Technology; Manchester Academic Health Science Centre; University of Manchester; UK Division of Cancer Sciences, University of Manchester, Manchester, England |
Incoming Links
Total number of triples: 428.